NextSeq 2000 Sequencing System

The National Institute of Child Health and Human Development is procuring a NextSeq 2000 Sequencing System to replace an aging NextSeq 500 sequencer at their Epigenomics Core Facility. This commercial item procurement requires a high-performance sequencing system with specific technical capabilities including maximum output of 540 Gb per run, 1.8B single reads, and 2 x 300bp read length, along with an embedded touchscreen monitor, on-instrument computer, control software, Dragen Bio-IT secondary analysis pipelines, installation, training, and a 12-month warranty. The solicitation is structured as an unrestricted Request for Quote under a Firm Fixed Price contract arrangement, governed by FAR Parts 12 and 13. Evaluation will focus on three primary factors: Salient Characteristics, Past Performance, and Price, with non-price factors being significantly more important than price considerations. Interested vendors must submit their responses by September 4, 2025 at 9:00 A.M. EST to Contracting Officer Michael Falzone.

This procurement does not include any small business set-aside designations and is unrestricted to all qualified vendors. No current contractors or incumbents are identified in the solicitation documentation, and no specific budget range or award value is disclosed. The contract requires delivery within 10 weeks of purchase order award to the facility located at 111 TW Alexander Drive in Research Triangle Park, Durham, North Carolina. The solicitation includes provisions for potential six-month performance extensions and allows for evaluation of options by adding their total price to the base requirement. The procurement falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a small business size standard of 1,000 employees, indicating the specialized nature of this sequencing equipment acquisition.